Advertisement
Journal Home
Search for

Volume 73, Issue 4, Pages 376-381 (April 2006)


View previous. 16 of 27 View next.

Bleeding patterns after use of levonorgestrel emergency contraceptive pills

Elizabeth G. RaymondaCorresponding Author Informationemail address, Alisa Goldbergb, James Trussellc, Melissa Haysa, Elizabeth Roachb, Douglas Taylora

Received 6 July 2005; received in revised form 12 October 2005; accepted 17 October 2005. published online 28 December 2005.

Refers to erratum:
Erratum to “Letter to the Editor” [Contraception 74 (2006) 349–350] , 06 April 2007
Elizabeth Raymond
Contraception
June 2007 (Vol. 75, Issue 6, Pages 476-477)
Full Text | Full-Text PDF (83 KB)

Abstract 

Objective

The objective of this study was to describe bleeding after use of an emergency contraceptive pill (ECP) regimen consisting of 1.5 mg of levonorgestrel in a single dose.

Methods

We asked 120 women who had been treated with the regimen to keep daily bleeding diaries for 9 weeks. We compared bleeding patterns observed after treatment with usual patterns reported by the participants and with patterns observed in a prior study on women who had not taken ECPs.

Results

Treatment in the first 3 weeks of the menstrual cycle significantly shortened that cycle as compared both with the usual cycle length and with the cycle duration in a comparison group. The magnitude of this effect was greater the earlier the pills were taken. In contrast, the duration of the first menstrual period after treatment increased significantly with cycle week of treatment and was longer in women who used the treatment than in those who did not. Intermenstrual bleeding occurred in only 5% of women in the first cycle after treatment.

Conclusions

The effect of the single-dose levonorgestrel ECP regimen on the timing and duration of the next menstrual period depends on when during the cycle the pills are taken. Intermenstrual bleeding following treatment is uncommon.

a Family Health International, PO Box 13950, Research Triangle Park, NC 27709, USA

b Planned Parenthood League of Massachusetts, Boston, MA, USA

c Office of Population Research, Princeton University, Princeton, NJ, USA

Corresponding Author InformationCorresponding author. Tel.: +1 919 405 1460; fax: +1 208 275 6440.

PII: S0010-7824(05)00424-5

doi:10.1016/j.contraception.2005.10.006


View previous. 16 of 27 View next.

Advertisement